{"filing":{"accession_number":"0001829126-26-006446","cik":"0001557376","ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"zeoscientifix_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626006446/zeoscientifix_8k.htm"},"events":[{"id":10855,"run_id":9524,"accession_number":"0001829126-26-006446","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.","company_name":"Zeo ScientifiX, Inc.","ticker":"ZEOX","filing_date":"2026-06-12","submitted_at":null,"items":[{"id":7276,"accession_number":"0001829126-26-006446","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:22:02.936261+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7276,"accession_number":"0001829126-26-006446","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:22:02.936261+00:00","company_name":"Zeo ScientifiX, Inc.","ticker":"ZEOX","filing_date":"2026-06-12"}]}